Annexon, Inc. (ANNX) vs MiMedx Group, Inc (MDXG)

Annexon, Inc. and MiMedx Group, Inc are both Biotechnology companies. Annexon, Inc. and MiMedx Group, Inc are of similar size ($720.4M and $686.5M). Annexon, Inc. has negative trailing earnings, so its P/E is not meaningful; MiMedx Group, Inc trades at 117×. MiMedx Group, Inc has the higher net margin (1.76% vs 0.00%) and the higher return on invested capital (5.62% vs 0.00%). Across the 14 metrics below, MiMedx Group, Inc leads on 12 and Annexon, Inc. on 2.

Valuation

Metric ANNX MDXG Biotechnology median
P/E n/m 116.75 7.88
P/S n/m 1.94 11.47
P/B 3.93 3.20 2.52
Price to free cash flow n/m 15.53 21.16
EV/EBITDA n/m 28.01 0.74
EV/Sales n/m 1.61 10.73
Earnings yield (31.87%) 0.86% (28.84%)
Free cash flow yield (26.41%) 6.44% (23.03%)

Profitability

Metric ANNX MDXG Biotechnology median
Gross margin 0.00% 78.85% 65.16%
Operating margin 0.00% 2.46% 0.00%
Net margin 0.00% 1.76% 0.00%
Free cash flow margin 0.00% 12.51% 0.00%
Return on equity (105.26%) 2.88% (57.72%)
Return on assets (79.38%) 2.18% (49.22%)
Return on invested capital 0.00% 5.62% 0.00%

Growth

Metric ANNX MDXG Biotechnology median
Revenue growth (TTM) — (2.36%) 5.64%
EPS growth (last fiscal year) (32.67%) 14.29% —
Revenue growth, 5-year CAGR — 11.02% 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ANNX MDXG Biotechnology median
Debt to equity 0.00 0.08 0.00
Current ratio 5.53 5.33 4.73
Net debt to EBITDA 1.11 (1.88) 0.96

Dividend

Metric ANNX MDXG Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric ANNX MDXG Biotechnology median
Market cap 720.40m 686.53m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack